Junxuan Lü

8.4k total citations
159 papers, 7.0k citations indexed

About

Junxuan Lü is a scholar working on Molecular Biology, Nutrition and Dietetics and Cancer Research. According to data from OpenAlex, Junxuan Lü has authored 159 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 47 papers in Nutrition and Dietetics and 44 papers in Cancer Research. Recurrent topics in Junxuan Lü's work include Selenium in Biological Systems (43 papers), Plant chemical constituents analysis (22 papers) and Trace Elements in Health (19 papers). Junxuan Lü is often cited by papers focused on Selenium in Biological Systems (43 papers), Plant chemical constituents analysis (22 papers) and Trace Elements in Health (19 papers). Junxuan Lü collaborates with scholars based in United States, South Korea and China. Junxuan Lü's co-authors include Cheng Jiang, Sung‐Hoon Kim, Howard E. Ganther, Hongbo Hu, Henry J. Thompson, Hyo‐Jeong Lee, Jinhui Zhang, Zaisen Wang, Mark Kaeck and Clement Ip and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Junxuan Lü

153 papers receiving 6.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Junxuan Lü 3.5k 2.2k 1.2k 813 735 159 7.0k
Naghma Khan 3.0k 0.9× 795 0.4× 617 0.5× 1.2k 1.4× 741 1.0× 82 8.5k
Vaqar M. Adhami 4.4k 1.3× 954 0.4× 1.0k 0.8× 1.2k 1.5× 1.2k 1.6× 122 10.3k
Cheng Jiang 1.8k 0.5× 1.5k 0.7× 540 0.4× 431 0.5× 471 0.6× 106 4.1k
Shigeyuki Sugie 2.3k 0.7× 560 0.3× 1.0k 0.9× 662 0.8× 919 1.3× 159 5.2k
Ranjana P. Bird 1.9k 0.6× 746 0.3× 764 0.6× 442 0.5× 1.3k 1.8× 94 5.2k
Clement Ip 3.1k 0.9× 5.2k 2.3× 1.1k 0.9× 613 0.8× 505 0.7× 129 8.5k
Hideki Mori 2.8k 0.8× 373 0.2× 947 0.8× 778 1.0× 821 1.1× 172 5.8k
Masao Hirose 3.2k 0.9× 489 0.2× 2.0k 1.6× 779 1.0× 717 1.0× 332 7.3k
Nanjoo Suh 5.0k 1.5× 547 0.2× 1.2k 1.0× 465 0.6× 1.3k 1.7× 108 7.9k
Fung‐Lung Chung 7.1k 2.1× 587 0.3× 1.4k 1.2× 1.4k 1.7× 674 0.9× 161 10.0k

Countries citing papers authored by Junxuan Lü

Since Specialization
Citations

This map shows the geographic impact of Junxuan Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxuan Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxuan Lü more than expected).

Fields of papers citing papers by Junxuan Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junxuan Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxuan Lü. The network helps show where Junxuan Lü may publish in the future.

Co-authorship network of co-authors of Junxuan Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Junxuan Lü. A scholar is included among the top collaborators of Junxuan Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junxuan Lü. Junxuan Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Junxuan, Cheng Jiang, & Hongbo Hu. (2025). Selenium compounds for cancer prevention and therapy – human clinical trial considerations. PubMed. 5(3). 203–230.
3.
Sun, Dongxiao, et al.. (2024). 2‐Deoxyglucose and hydroxychloroquine HPLC‐MS–MS analytical methods and pharmacokinetic interactions after oral co‐administration in male rats. Pharmacology Research & Perspectives. 12(1). e1173–e1173. 2 indexed citations
4.
Bian, Tengfei, K. Ballas, Allison M. Lynch, et al.. (2023). Opportunities and Challenges of Kava in Lung Cancer Prevention. International Journal of Molecular Sciences. 24(11). 9539–9539. 7 indexed citations
5.
Karelia, Deepkamal, Haifeng Wang, Wesley M. Raup‐Konsavage, et al.. (2023). Library Screening and Preliminary Characterization of Synthetic Cannabinoids Against Prostate and Pancreatic Cancer Cell Lines. Cannabis and Cannabinoid Research. 9(2). 523–536. 1 indexed citations
6.
7.
Wang, Yi, Sreekanth C. Narayanapillai, Katelyn Tessier, et al.. (2020). The Impact of One-week Dietary Supplementation with Kava on Biomarkers of Tobacco Use and Nitrosamine-based Carcinogenesis Risk among Active Smokers. Cancer Prevention Research. 13(5). 483–492. 14 indexed citations
8.
Zhang, Yong, Yinhui Dong, Michael W. Melkus, et al.. (2018). Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound Bufalin. Molecular Cancer Therapeutics. 17(11). 2341–2352. 41 indexed citations
9.
Wang, Lei, Xiaolan Guo, Ji Wang, et al.. (2015). Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten -Knockout Mouse. Cancer Prevention Research. 9(1). 35–42. 20 indexed citations
10.
Zhang, Jinhui, Wei Wu, Peixin Jiang, et al.. (2015). Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate Carcinogenesis. Cancer Prevention Research. 8(9). 835–844. 19 indexed citations
11.
Narayanapillai, Sreekanth C., Silvia Balbo, Bo Zhou, et al.. (2014). Kava Blocks 4-(Methylnitrosamino)-1-(3-pyridyl)-1-Butanone–Induced Lung Tumorigenesis in Association with Reducing O6 -methylguanine DNA Adduct in A/J Mice. Cancer Prevention Research. 7(1). 86–96. 31 indexed citations
12.
Lee, Hyo‐Jeong, Soo‐Jin Jeong, Yongsup Park, et al.. (2011). Oral administration of penta-O-galloyl- -D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition. Carcinogenesis. 32(6). 804–811. 71 indexed citations
13.
Kim, Seung‐Hyung, Seung‐Hyung Kim, Jeong‐Eun Lee, et al.. (2011). Ka-mi-kae-kyuk-tang oriental herbal cocktail attenuates cyclophosphamide-induced leukopenia side effects in mouse. Immunopharmacology and Immunotoxicology. 33(4). 682–690. 1 indexed citations
14.
Lee, Jae Ho, Sun Choi, Yoonji Lee, et al.. (2010). Herbal Compound Farnesiferol C Exerts Antiangiogenic and Antitumor Activity and Targets Multiple Aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) Signaling Cascades. Molecular Cancer Therapeutics. 9(2). 389–399. 53 indexed citations
15.
Wang, Lei, Melissa J.L. Bonorden, Guangxun Li, et al.. (2009). Methyl-Selenium Compounds Inhibit Prostate Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate Model with Survival Benefit. Cancer Prevention Research. 2(5). 484–495. 99 indexed citations
16.
Lee, Hyo‐Jeong, Kwang Seok Ahn, Sun-Hee Kim, et al.. (2009). Cyclooxygenase-2/prostaglandin E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells. Cancer Letters. 280(1). 93–100. 80 indexed citations
17.
Kim, Sung Hoon, Cheng Jiang, Junming Guo, et al.. (2007). Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells. Cancer Epidemiology and Prevention Biomarkers. 16. 1 indexed citations
19.
Lee, Eun‐Ok, Hyo‐Jeong Lee, Junxuan Lü, & Sung Hoon Kim. (2005). Anti-angiogenic and anti-tumor activities of Kamikaekyuk-tang. 40–50.
20.
Lü, Junxuan, et al.. (1995). Ras may mediate mammary cancer promotion by high fat. Nutrition and Cancer. 23(3). 283–290. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026